Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
UK, France, Germany trigger UN sanctions on Iran...
What did Obama know about the Trump–Russia probe?...
Navigating Uncertainty: How Trump’s Tariffs Are Affecting the...
Capital Raise Presentation
Crypto Market Update: ETH Funds Absorb US$1.3 Billion...
White House demands all Gaza hostages return home...
Trump asks SCOTUS to uphold freeze on billions...
Bill Gates met with Trump to talk ‘importance...
CDC Director Susan Monarez refuses to be fired...
Is Trump considering bold Africa play to push...
UK, France, Germany trigger UN sanctions on Iran...
What did Obama know about the Trump–Russia probe?...
Navigating Uncertainty: How Trump’s Tariffs Are Affecting the...
Capital Raise Presentation
Crypto Market Update: ETH Funds Absorb US$1.3 Billion...
White House demands all Gaza hostages return home...
Trump asks SCOTUS to uphold freeze on billions...
Bill Gates met with Trump to talk ‘importance...
CDC Director Susan Monarez refuses to be fired...
Is Trump considering bold Africa play to push...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

23andMe to delist from Nasdaq, deregister with SEC

by admin May 29, 2025
May 29, 2025
23andMe to delist from Nasdaq, deregister with SEC

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for Chapter 11 bankruptcy protection in March.

23andMe said it will file a Form 25 Notification of Delisting with the SEC on or around June 6, which would subsequently remove the stock from listing and registering with the Nasdaq.

The company said the Nasdaq had originally informed the company that a Form 25 would be filed in March, but since the exchange has not yet submitted the filing, 23andMe is doing so voluntarily.

23andMe exploded into the mainstream because of its at-home DNA testing kits that allowed customers to examine their genetic profiles. At its peak, the company was valued at around $6 billion.

But after going public via a merger with a special purpose acquisition company in 2021, the company struggled to generate recurring revenue and stand up viable research or therapeutics businesses.

Regeneron’s deal is still subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri. Pending approval, it’s expected to close in the third quarter of this year.

This post appeared first on NBC NEWS

previous post
Dick’s Sporting Goods stands by full-year guidance — even with tariffs looming
next post
Blue Lagoon Resources to Participate in Canada’s Premier Mining Investor Conference in Quebec City

You may also like

Super Micro’s $50 billion stock collapse underscores risk...

November 2, 2024

To fix Starbucks, incoming CEO will have to...

August 20, 2024

Markets are counting on the Fed to head...

August 8, 2024

Americans who moved abroad say this big expense...

August 8, 2024

Gov. Gavin Newsom says he will provide residents...

November 26, 2024

Wealthy investors find opportunities in stock market sell-offs

August 13, 2024

Drone company’s stock soars after it appoints Donald...

November 29, 2024

U.S. could take stakes in more firms, White...

August 26, 2025

Wall Street expects Trump presidency will unlock deal-making

November 9, 2024

Here’s what the NBA’s new media deal means...

July 26, 2024

Super Micro’s $50 billion stock collapse underscores risk...

November 2, 2024

To fix Starbucks, incoming CEO will have to...

August 20, 2024

Markets are counting on the Fed to head...

August 8, 2024

Americans who moved abroad say this big expense...

August 8, 2024

Gov. Gavin Newsom says he will provide residents...

November 26, 2024

Wealthy investors find opportunities in stock market sell-offs

August 13, 2024

Drone company’s stock soars after it appoints Donald...

November 29, 2024

U.S. could take stakes in more firms, White...

August 26, 2025

Wall Street expects Trump presidency will unlock deal-making

November 9, 2024

Here’s what the NBA’s new media deal means...

July 26, 2024

Recent Posts

  • White House demands all Gaza hostages return home ‘this week’ amid stalled talks
  • Trump asks SCOTUS to uphold freeze on billions in USAID payments
  • Bill Gates met with Trump to talk ‘importance of US global health programs and health research’: spox
  • CDC Director Susan Monarez refuses to be fired as other officials call it quits
  • Is Trump considering bold Africa play to push back on China, Russia and Islamic terrorists?

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (896)
    • Investing (2,851)
    • Politics (3,498)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.